BRPI1011507A2 - anticorpo antagonista específico para heterodímero alfa-4-beta-7 - Google Patents

anticorpo antagonista específico para heterodímero alfa-4-beta-7

Info

Publication number: BRPI1011507A2
Authority: BR; Brazil
Prior art keywords: alpha4; beta; antagonist antibody; specific antagonist; heterodimer specific
Prior art date: 2009-03-20

Application number

BRPI1011507A

Other languages

English (en)

Inventor

Frederick W Jacobsen

Hailing Hsu

Ian Foltz

Taruna Arora

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-20

Filing date

2010-03-16

Publication date

2016-03-22

2010-03-16 Application filed by Amgen Inc filed Critical Amgen Inc

2010-03-16 Priority claimed from PCT/US2010/027422 external-priority patent/WO2010107752A2/en

2016-03-22 Publication of BRPI1011507A2 publication Critical patent/BRPI1011507A2/pt

Links

239000005557 antagonist Substances 0.000 title 1
239000000833 heterodimer Substances 0.000 title 1

BRPI1011507A 2009-03-20 2010-03-16 anticorpo antagonista específico para heterodímero alfa-4-beta-7 BRPI1011507A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US16215409P	2009-03-20	2009-03-20
US20682910P	2010-02-22	2010-02-22
PCT/US2010/027422 WO2010107752A2 (en)	2009-03-20	2010-03-16	Alpha-4-beta-7 heterodimer specific antagonist antibody

Publications (1)

Publication Number	Publication Date
BRPI1011507A2 true BRPI1011507A2 (pt)	2016-03-22

Family

ID=55534018

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1011507A BRPI1011507A2 (pt)	2009-03-20	2010-03-16	anticorpo antagonista específico para heterodímero alfa-4-beta-7

Country Status (1)

Country	Link
BR (1)	BRPI1011507A2 (pt)

2010
- 2010-03-16 BR BRPI1011507A patent/BRPI1011507A2/pt not_active Application Discontinuation

Similar Documents

Publication	Publication Date	Title
HUS2200033I1 (hu)	2022-08-28	CGRP receptor antagonisták
LTPA2019011I1 (lt)	2019-05-10	CGRP antikūnai
BRPI1014262A2 (pt)	2017-05-23	anticorpos específicos para caderina-17
DK2821407T3 (da)	2017-01-02	Piperidinoncarboxamidazaindan-cgrp receptorantagonister
EP2473531A4 (en)	2013-05-01	Anti-gitr antibodies
EP2482848A4 (en)	2013-04-17	Endoglin antibodies
BR112012030311A2 (pt)	2017-01-24	anticorpo
HUE038962T2 (hu)	2018-12-28	DLL3-ellenes antitest
IL239965A0 (en)	2015-08-31	Alpha-4-beta-7 heterodimeric specific antagonist antibody
PT2406284T (pt)	2016-09-29	Anticorpos anti-bcma
EP2629796A4 (en)	2015-01-28	ANTIBODY
DK2483310T3 (da)	2014-09-01	Bispecifik dødsreceptor-agonistiske antistoffer
BRPI1006519A2 (pt)	2016-08-09	formulação de anticorpos
DK2443104T3 (da)	2013-05-06	Disubstituerede phthalazin-hedgehog-sti-antagonister
SMT201700083B (it)	2017-03-08	Anticorpi monoclonali
EP2665707A4 (en)	2015-01-14	ANTAGONISTS OF THE MINERALOCORTICOID RECEPTOR
CO6791565A2 (es)	2013-11-14	Anticuerpos anti-notch1
PT2793883T (pt)	2018-07-18	Antagonistas de trpm8
BRPI0908008A2 (pt)	2015-08-18	Farmacóforo dual - pde4-antagonistas muscarínicos
BR112012005119A2 (pt)	2016-11-22	novos antagonistas de hepcidina etanodiaminas
ES1071355Y (es)	2010-05-13	Dispositivo antisismico para edificios
EP2408304A4 (en)	2012-12-12	CGRP RECEPTOR ANTAGONISTS
BR112012011093A2 (pt)	2019-09-24	antígenos para actinobacillus suis
BRPI1011507A2 (pt)	2016-03-22	anticorpo antagonista específico para heterodímero alfa-4-beta-7
TH0901005583A (th)	2015-05-29	แอนติ-igf แอนติบอดี

Legal Events

Date	Code	Title	Description
2018-02-27	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-07-09	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.
2020-06-23	B07E	Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-10-27	B07A	Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
2021-05-11	B09B	Patent application refused [chapter 9.2 patent gazette]
2021-07-27	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL